V025-9998 Screening compound: 4-chloro-N-(2-{4-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

V025-9998 Screening compound: 4-chloro-N-(2-{4-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
V025-9998 Screening compound: 4-chloro-N-(2-{4-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-9998
4-chloro-N-(2-{4-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-9998

Molecular Formula

C29H31Cl3N6O3 (C29 H31 Cl3 N6 O3)

Compound Name

4-chloro-N-(2-{4-[6-(2,4-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

IUPAC name

4-chloro-N-(2-{4-[6-(24-dichlorophenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

SMILES

O=C(CN(CCN1CCOCC1)C(c(cc1)ccc1Cl)=O)N(CC1)CCN1c(cc1)nnc1-c(ccc(Cl)c1)c1Cl

InChI

InChI=1S/C29H31Cl3N6O3/c30-22-3-1-21(2-4-22)29(40)38(10-9-35-15-17-41-18-16-35)20-28(39)37-13-11-36(12-14-37)27-8-7-26(33-34-27)24-6-5-23(31)19-25(24)32/h1-8,19H,9-18,20H2

InChI Key

CLMDTMOCLDLWLU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19828629

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

617.96

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.819

Distribution Coefficient, logD

3.814

Water Solubility, LogSw

-4.51

Polar Surface Area

68.635

Acid Dissociation Constant (pKa)

23.05

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.90

V025-9998 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V025-9998 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-9998?
Check Price and Availability of V025-9998, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-9998 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-9998
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-9998
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-9998 available by request